Table 1.
Demographic, ophthalmologic characteristics and optical coherence tomography parameters in patients with exudative age-related macular degeneration before and after the loading phase of intravitreal injections of bevacizumab
| Parameters | Baseline | After the loading phase | p value |
|---|---|---|---|
| Eyes (n) | 38 | – | – |
| Sex (male/female) (n) | 8/11 | – | – |
| Age (years) | 72.5 ± 7.46 | – | – |
| BCVA (logMAR) | 0.54 ± 0.43 | 0.56 ± 0.43 | 0.621 |
| CMT (µm) | 372.47 ± 167.05 | 320.63 ± 175.05 | 0.039 |
| SFCT (µm) | 189.21 ± 37.66 | 170.37 ± 37.96 | < 0.001 |
| CT nasal 500 µm | 181.53 ± 36.99 | 163.21 ± 37.02 | < 0.001 |
| CT temporal 500 µm | 182.26 ± 36.77 | 164.68 ± 37.32 | < 0.001 |
| CT average (µm) | 184.33 ± 36.81 | 166.09 ± 37.06 | < 0.001 |
Data are expressed as the mean ± standard deviation (SD) unless indicated otherwise
p values were calculated using the paired Student’s test, with p < 0.05 indicating a significant difference
BCVA Best corrected visual acuity, logMAR logarithm of the minimum angle of resolution, CMT central macular thickness, SFCT subfoveal choroidal thickness, CT choroidal thickness